These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 9218596

  • 1. IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease.
    de Jong R, Janson AA, Faber WR, Naafs B, Ottenhoff TH.
    J Immunol; 1997 Jul 15; 159(2):786-93. PubMed ID: 9218596
    [Abstract] [Full Text] [Related]

  • 2. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T, Kraakman EM, Cornelisse YE, Haanen JB, Spits H, De Vries RR, Ottenhoff TH.
    J Immunol; 1993 May 15; 150(10):4641-51. PubMed ID: 8482851
    [Abstract] [Full Text] [Related]

  • 3. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P, Agis F, Wallach D, Flageul B, Cottenot F, Augier J, Bach MA.
    J Immunol; 1986 Jun 01; 136(11):4255-63. PubMed ID: 2422278
    [Abstract] [Full Text] [Related]

  • 4. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N, Gelber RH, Larrick JW, Sasaki DT, Brennan PJ, Engleman EG.
    J Immunol; 1985 Aug 01; 135(2):1443-9. PubMed ID: 2989366
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K, Khanna N, Chattree V, Pal PC, Haq W, Rao DN.
    Int Immunopharmacol; 2003 Nov 01; 3(12):1589-600. PubMed ID: 14555284
    [Abstract] [Full Text] [Related]

  • 7. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy.
    Sieling PA, Abrams JS, Yamamura M, Salgame P, Bloom BR, Rea TH, Modlin RL.
    J Immunol; 1993 Jun 15; 150(12):5501-10. PubMed ID: 8515073
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mycobacterial antigen(s) induce anergy by altering TCR- and TCR/CD28-induced signalling events: insights into T-cell unresponsiveness in leprosy.
    Dagur PK, Sharma B, Kumar G, Khan NA, Katoch VM, Sengupta U, Joshi B.
    Mol Immunol; 2010 Feb 15; 47(5):943-52. PubMed ID: 20018378
    [Abstract] [Full Text] [Related]

  • 11. Genetic control of murine T cell proliferative responses to Mycobacterium leprae. V. Evidence for cross-reactivity between host antigens and Mycobacterium leprae.
    Harris DP, Jones AG, Wade S, Krahenbuhl JL, Gillis TP, Watson JD.
    J Immunol; 1988 Sep 01; 141(5):1695-700. PubMed ID: 2970509
    [Abstract] [Full Text] [Related]

  • 12. Assessment of the immune deficit in leprosy patients and the effect of recombinant IL-2 in vitro.
    Locniskar M, McEniry DW, Mudd DW, Rose P, Lucas DC, Larrick J, McAdam KP.
    Int J Lepr Other Mycobact Dis; 1987 Jun 01; 55(2):249-60. PubMed ID: 3298472
    [Abstract] [Full Text] [Related]

  • 13. IL-12 produced by antigen-presenting cells induces IL-2-independent proliferation of T helper cell clones.
    Maruo S, Toyo-oka K, Oh-hora M, Tai XG, Iwata H, Takenaka H, Yamada S, Ono S, Hamaoka T, Kobayashi M, Wysocka M, Trinchieri G, Fujiwara H.
    J Immunol; 1996 Mar 01; 156(5):1748-55. PubMed ID: 8596023
    [Abstract] [Full Text] [Related]

  • 14. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 01; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 15. IL-12 activates IFN-gamma production through the preferential activation of CD30+ T cells.
    Alzona M, Jäck HM, Fisher RI, Ellis TM.
    J Immunol; 1995 Jan 01; 154(1):9-16. PubMed ID: 7995963
    [Abstract] [Full Text] [Related]

  • 16. IL-15, an immunomodulator of T cell responses in intracellular infection.
    Jullien D, Sieling PA, Uyemura K, Mar ND, Rea TH, Modlin RL.
    J Immunol; 1997 Jan 15; 158(2):800-6. PubMed ID: 8992997
    [Abstract] [Full Text] [Related]

  • 17. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients.
    Brett SJ, Kingston AE, Colston MJ.
    Clin Exp Immunol; 1987 Jun 15; 68(3):510-20. PubMed ID: 3308217
    [Abstract] [Full Text] [Related]

  • 18. Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells.
    Yogi Y, Endoh M, Banba T, Okamura H, Nomaguchi H.
    Int J Lepr Other Mycobact Dis; 1998 Dec 15; 66(4):464-74. PubMed ID: 10347567
    [Abstract] [Full Text] [Related]

  • 19. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
    Thole JE, Janson AA, Kifle A, Howe RC, McLean K, Nurilygn A, Filley E, Shannon EJ, Bulla GJ, Hermans J.
    Int J Lepr Other Mycobact Dis; 1995 Sep 15; 63(3):369-80. PubMed ID: 7594920
    [Abstract] [Full Text] [Related]

  • 20. rIL 2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL 1 and IL 2.
    Ben Aribia MH, Leroy E, Lantz O, Métivier D, Autran B, Charpentier B, Hercend T, Senik A.
    J Immunol; 1987 Jul 15; 139(2):443-51. PubMed ID: 3110271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.